The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome

Area of Science:

• Genetics
• Metabolic Diseases
• Molecular Biology

Background:

• Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS) result from complex genetic and environmental interactions.
• Understanding the genetic underpinnings of these conditions is crucial for developing targeted interventions.
• Male populations represent a significant demographic affected by T2DM and MetS.

Purpose of the Study:

• To investigate the association between six common gene polymorphisms and T2DM and MetS in males.
• To identify specific genetic variants that may confer risk or protection against these metabolic disorders.
• To explore potential gene-environment interactions, particularly concerning alcohol consumption.

Main Methods:

• Genotyping of six common gene polymorphisms (ACE ID, eNOS 4a/b, ATR1 A1166C, OXTR (A>G), SOD1 +35A/C, CAT-21A/T) using PCR or PCR-RFLP.
• Comparison of genotype frequencies between T2DM patients, MetS patients, and healthy controls (HC).
• Statistical analysis to determine odds ratios (O.R.) and p-values for associations.

Main Results:

• The SOD1 AA genotype and the combination of ACE I and OXTR1 A alleles were found to be protective against T2DM.
• SOD1 AA and AC genotypes were associated with favorable triglyceride and HDL cholesterol levels in T2DM patients.
• The ACE DD genotype was more frequent in hypertensive T2DM patients and in T2DM patients who consumed alcohol. Alcohol consumption in T2DM patients showed increased frequency of ACE DD with eNOS bb or OXTR G alleles.
• No significant associations were found between the studied gene polymorphisms and MetS.

Conclusions:

• Specific genetic polymorphisms, namely SOD1 AA and the combined ACE I/OXTR1 A alleles, demonstrate a protective role in the development of T2DM in males.
• These genetic factors may also influence lipid profiles in T2DM patients.
• The ACE DD genotype, in conjunction with alcohol consumption and other genetic variants (eNOS bb, OXTR G), may indicate an increased risk or specific phenotype in T2DM patients, highlighting potential gene-environment interactions.